Fundraising Foxretinalscreenings
1 known investors
Find your way into retinalscreenings
Sign up to see every warm intro you have to retinalscreenings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the retinalscreenings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
IRIS is cloud-based, camera-agnostic retinal screening software that lets healthcare providers capture, enhance, and diagnose diabetic retinopathy, with board-certified eye specialists interpreting the images. It serves hospitals, health systems, federally qualified health centers, health plans, labs, pharmacies, and health risk assessment companies to close care gaps and reduce costs.
Investors · 1
Frequently asked questions
- What does retinalscreenings do?
- IRIS is cloud-based, camera-agnostic retinal screening software that lets healthcare providers capture, enhance, and diagnose diabetic retinopathy, with board-certified eye specialists interpreting the images. It serves hospitals, health systems, federally qualified health centers, health plans, labs, pharmacies, and health risk assessment companies to close care gaps and reduce costs.
- Who are retinalscreenings's investors?
- retinalscreenings's investors include Florida Technology Seed Capital Fund.